Finance

Lists
ZVRA:NASDAQ
Zevra Therapeutics Inc
11,18 $
-1,24%
(-0,14) 1D
13 հոկ, 09:34:53 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZVRA...
Open
11,33 $
High
11,33 $
Low
11,18 $
Mkt. cap
663,91 մլն
Avg. vol.
953,51 հզր
Volume
80,00
P/E ratio
11,67
52-wk high
15,04 $
52-wk low
8,01 $
EPS
0,96 $
Beta
0,98
Shares outstanding
59,38 մլն
No. of employees
61
Open
11,33 $
High
11,33 $
Low
11,18 $
Mkt. cap
663,91 մլն
Avg. vol.
953,51 հզր
Volume
80,00
P/E ratio
11,67
52-wk high
15,04 $
52-wk low
8,01 $
EPS
0,96 $
Beta
0,98
Shares outstanding
59,38 մլն
No. of employees
61
News stories
From web sources and news partners
About Zevra Therapeutics Inc
CEO-
Employees61
Founded2006
Headquarters-
Sector-
Websitezevra.com
Analyst ratings
Based on 9 analysts giving stock ratings to ZVRA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for ZVRA in the last 3 months.
Highest
Current 11,18 $
35,00 $ (+213,06%)
Average
25,25 $ (+125,85%)
Lowest
20,00 $ (+78,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
09/30/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
26,00 $
+132,6%
09/21/2026
Sumant Kulkarni
Canaccord Genuity
Buy
Reiterated
20,00 $
+78,9%
08/11/2026
Jason McCarthy
Maxim Group
Buy
Maintained
35,00 $
+213,1%
08/06/2026
Eddie Hickman
Guggenheim
Buy
Maintained
23,00 $
+105,7%
08/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
21,00 $
+87,8%
08/06/2026
Kambiz Yazdi
BTIG
Buy
Maintained
24,00 $
+114,7%
08/05/2026
Jason Butler
Citizens JMP
Buy
Maintained
28,00 $
+150,4%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
25,00 $
+123,6%
08/05/2026
Unknown Analyst
Roth MKM
Buy
Maintained
21,00 $
+87,8%
05/07/2026
Last report
05 օգս, 2026 թ.
Fiscal period
Q2 2026
0,25 $ / 0,18 $
+41,51%beat
Revenue / Est. (USD)
39,66 մլն / 34,84 մլն
+13,85%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
26,06 մլն
34,12 մլն
36,22 մլն
39,66 մլն
Cost of goods sold
1,24 մլն
1,52 մլն
1,90 մլն
1,52 մլն
Cost of revenue
1,24 մլն
1,52 մլն
1,90 մլն
1,52 մլն
Research and development expenses
3,43 մլն
2,52 մլն
4,39 մլն
4,49 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,94 մլն
20,45 մլն
20,78 մլն
16,56 մլն
Operating expense
20,68 մլն
23,29 մլն
25,49 մլն
21,36 մլն
Total operating expenses
21,92 մլն
24,81 մլն
27,39 մլն
22,89 մլն
Operating income
4,14 մլն
9,32 մլն
8,83 մլն
16,78 մլն
Other non operating income
-5,51 մլն
3,56 մլն
-6,25 մլն
-6,41 մլն
EBT including unusual items
-977,00 հզր
12,67 մլն
44,80 մլն
12,79 մլն
EBT excluding unusual items
-1,10 մլն
12,64 մլն
4,46 մլն
12,93 մլն
Income tax expense
-433,00 հզր
501,00 հզր
6,91 մլն
4,04 մլն
Effective tax rate
44,32%
3,96%
15,43%
31,59%
Other operating expenses
-
-
-
-
Net income
-544,00 հզր
12,16 մլն
37,89 մլն
8,75 մլն
Net profit margin
-2,09%
35,65%
104,61%
22,07%
Earnings per share
-0,01
0,19
0,18
0,25
Interest and investment income
2,31 մլն
1,71 մլն
3,59 մլն
2,56 մլն
Interest expense
-2,05 մլն
-1,95 մլն
-1,71 մլն
-
Net interest expenses
262,00 հզր
-236,00 հզր
1,88 մլն
2,56 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
4,54 մլն
9,68 մլն
9,20 մլն
17,14 մլն
Gain or loss from assets sale
-
63,00 հզր
-43,31 մլն
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps